Top 10 Mistakes Made by Entrepreneurs… [Texchange]

Entrepreneurs repeatedly make mistakes that come back to haunt them when they go to raise money or sell their company.  These mistakes range from choosing the wrong business structure, issuing founders stock without vesting, failing to handle the "toxic" shareholder, and failing to protect your intellectual property.  Paul Pryzant, a leading corporate attorney with Locke Liddell & Sapp LLP, and Dr. Russ Lebovitz, the CEO of C Sixty, Inc., a leading nanotechnology company, will lead our program discussion on what these common mistakes are and how to avoid them.  Please join us for this invaluable program and share your own stories about the common mistakes you have seen.

Paul Pryzant practices law with Locke Liddell and Sapp LLP, and has over 20 years experience as a corporate and securities attorney.  Paul’s practice includes mergers and acquisitions, private placements, venture capital, and Internet commerce, and works regularly with start-up companies and entrepreneurs.  Paul's experience includes serving as the General Counsel of a NYSE-listed truck parts distribution company that grew aggressively through acquisitions.  Additionally, Paul was the General Counsel of a leading Internet chemical exchange.  He received his B.S. from The Wharton School at the University of Pennsylvania, and J.D. from the University of Texas at Austin.

Dr. Russell M. Lebovitz is the President and CEO of C Sixty, Inc., an early stage nanotechnology company pioneering the development of new drugs based on the unique chemistry of water-soluble fullerenes, a recently discovered class of highly structured, small molecules.  Russ worked for 15 + years as a senior scientist and research physician in a variety of academic settings. In 1995 and 1996 Russ studied management and finance at Rice and Stanford Universities and subsequently worked for a variety of early and intermediate-stage biotech and medical device companies throughout the US. Russ has also worked on global projects in operations, marketing and finance with a number of Fortune 100 technology companies including Royal Dutch Shell, Johnson & Johnson, Compaq Computer and JPMorganChase, as well as with leading venture capital and investment banking firms. Russ has raised over $100 million for early and intermediate stage biomedical technology companies.

Texchange Event Format:
Meetings start with refreshments and informal conversation followed by a sit-down dinner where attendees can become acquainted with others at their table. After the speaker's presentation, each table discusses a pre-set technology or entrepreneurial topic among themselves. Everyone is encouraged to share their viewpoints and, especially, share knowledge gained through their own unique experiences. Afterwards, there is a moderated "open table" discussion.

Register Online


Organizer Paul Schatz


Tue, May. 17, 2005
5:30 p.m. - 8:30 p.m. US/Central


Houstonian Hotel, Forest III room
111 N. Post Oak Ln
Houston, Texas 77024